SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000875320-15-000056
Filing Date
2015-10-30
Accepted
2015-10-30 16:23:50
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2015q310-q.htm 10-Q 1433834
2 EXHIBIT 10.1 a2015q310-q_exhibit101.htm EX-10.1 133550
3 EXHIBIT 31.1 a2015q310-q_exhibit311.htm EX-31.1 14490
4 EXHIBIT 31.2 a2015q310-q_exhibit312.htm EX-31.2 14324
5 EXHIBIT 31.2 a2015q310-q_exhibit321.htm EX-31.2 11724
  Complete submission text file 0000875320-15-000056.txt   7590632

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vrtx-20150930.xml EX-101.INS 1716981
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20150930.xsd EX-101.SCH 52938
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrtx-20150930_cal.xml EX-101.CAL 88916
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrtx-20150930_def.xml EX-101.DEF 231029
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20150930_lab.xml EX-101.LAB 686585
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20150930_pre.xml EX-101.PRE 374678
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 151187797
SIC: 2834 Pharmaceutical Preparations